Skip to main content

Table 2 Relationship between RPL35A expression and tumor characteristics in patients with gastric cancer

From: RPL35A is a key promotor involved in the development and progression of gastric cancer

Features

No. of patients

RPL35A expression

P value

Low

High

All patients

110

65

45

 

Age (years)

   

0.070

 < 64

53

36

17

 

 ≥ 64

57

29

28

 

Gender

   

0.869

 Male

84

50

34

 

 Female

26

15

11

 

T Infiltrate

   

0.042

 T1

5

4

1

 

 T2

17

11

6

 

 T3

65

41

24

 

 T4

23

9

14

 

Lymphatic metastasis (N)

   

0.754

 N0

20

13

7

 

 N1

18

12

6

 

 N2

26

12

14

 

 N3

46

28

18

 

Stage

   

0.631

 I

9

5

4

 

 II

32

21

11

 

 III

68

38

30

 

 IV

1

1

0

 

Tumor size

   

0.591

 < 5 cm

46

26

20

 

 ≥ 5 cm

55

34

21

 

Vessel carcinoma embolus

   

0.539

 0

26

14

12

 

 1

54

33

21

 

Nerve tumor infiltrates

   

0.425

 0

36

22

14

 

 1

20

10

10

 

Expession of Ki67

   

0.404

 < 60%

47

25

22

 

 ≥ 60%

52

32

20

 

Expession of CD34

   

0.346

 No

15

6

9

 

 Yes

29

16

13

 

Expession of EGFR

   

0.531

 No

85

47

38

 

 Yes

14

9

5

 

Expession of VEGF

   

0.343

 No

34

17

17

 

 Yes

65

39

26

 

Expession of CDX2

   

0.892

 No

18

10

8

 

 Yes

82

47

35

 

Expession of Her2

   

0.948

 No

72

41

31

 

 Yes

26

15

11